109 related articles for article (PubMed ID: 3863029)
1. Effect of oral penbutolol on renal haemodynamics of hypertensive patients with renal insufficiency.
Bailey RR; Carlson RV; Walker RJ; Swainson CP
N Z Med J; 1985 Aug; 98(785):683-5. PubMed ID: 3863029
[TBL] [Abstract][Full Text] [Related]
2. Efficacy of penbutolol + piretanide combinations in the treatment of arterial hypertension.
Verho M; Rangoonwala B; Pahnke K; Freude J; Häringer E
Drugs Exp Clin Res; 1985; 11(10):717-23. PubMed ID: 3915460
[TBL] [Abstract][Full Text] [Related]
3. [Effect of penbutolol on the hemodynamics in patients with hypertensive disease].
Demin AA; Mitrokhin VE
Farmakol Toksikol; 1986; 49(5):74-6. PubMed ID: 3770181
[TBL] [Abstract][Full Text] [Related]
4. Efficacy of penbutolol and a combination of a low dose of penbutolol with piretanide in the treatment of mild to moderate hypertension.
Graml E; Verho M; Rangoonwala B; Englert R; Häringer E; Pahnke K
Pharmatherapeutica; 1985; 4(4):236-43. PubMed ID: 3903788
[TBL] [Abstract][Full Text] [Related]
5. [Treatment of essential mild-to-moderate arterial hypertension with once-daily penbutolol. Controlled clinical study vs atenolol].
Nami R; Martinelli M; Bianchini C; Gennari C
Minerva Med; 1988 Nov; 79(11):965-71. PubMed ID: 3059235
[TBL] [Abstract][Full Text] [Related]
6. [Clinical evaluation of penbutolol (Hoe 893d) (beta adrenergic blocker), alone and in combination with hydrochlorothiazide, in the treatment of arterial hypertension. II. Effect on plasma electrolytes, renal function, plasma renin and aldosterone activity and risk factors, including plasma lipids].
Ocón J; Piña C; Castellet R; Vila R; del Río G; Arnau C
Med Clin (Barc); 1985 Jun; 85(2):53-7. PubMed ID: 3894828
[No Abstract] [Full Text] [Related]
7. Penbutolol in hypertension, alone and in combination with furosemide. A long-term multicentre study.
Vander Elst E; Lawrence J; Rössner M; Mertens H
S Afr Med J; 1983 Jan; 63(5):143-7. PubMed ID: 6336854
[TBL] [Abstract][Full Text] [Related]
8. Efficacy of a low fixed-dose combination of penbutolol with piretanide in the treatment of mild to moderate hypertension: a double-blind study against placebo.
Yasky J; Verho M; Rangoonwala B
Pharmatherapeutica; 1986; 4(9):607-16. PubMed ID: 3763655
[TBL] [Abstract][Full Text] [Related]
9. [Effect of penbutolol (HOE 893 d), a non-selective beta blocker, in the control of essential arterial hypertension].
Calle Pascual AL; Charro Salgado AL
Med Clin (Barc); 1983 Feb; 80(5):201-3. PubMed ID: 6855302
[No Abstract] [Full Text] [Related]
10. Efficacy of penbutolol and a fixed combination of penbutolol with furosemide in the treatment of hypertension.
Haeringer E; Graml W; Rangoonwala B; Roessner M
Pharmatherapeutica; 1982; 3(4):233-42. PubMed ID: 7146039
[TBL] [Abstract][Full Text] [Related]
11. [Validity of the use of penbutolol in essential arterial hypertension].
Pepe S; Scalici G; D'Angelo A; Curiale B; Corrao S; Agnello C
Minerva Med; 1990 Jun; 81(6):471-3. PubMed ID: 2359502
[TBL] [Abstract][Full Text] [Related]
12. Contrasting renal haemodynamic responses to the angiotensin converting enzyme inhibitor enalapril and the beta-adrenergic antagonist metoprolol in essential hypertension.
O'Connor DT; Mosley CA; Cervenka J; Bernstein KN
J Hypertens Suppl; 1984 Dec; 2(2):S89-92. PubMed ID: 6100882
[TBL] [Abstract][Full Text] [Related]
13. Comparative haemodynamic dose-response effects of intravenous propranolol, acebutolol and penbutolol in angina pectoris.
Silke B; Nelson GI; Verma SP; Ahuja RC; Okoli RC; Hussain M; Taylor SH
Herz; 1984 Feb; 9(1):57-64. PubMed ID: 6368345
[TBL] [Abstract][Full Text] [Related]
14. Penbutolol in hypertension: evaluation of a new beta-adrenergic blocking drug.
Bett JH; Wilkinson RK; Williams J; Ryan H
Med J Aust; 1980 Jan; 1(1):30-1. PubMed ID: 6987484
[TBL] [Abstract][Full Text] [Related]
15. Influence of treatment by betaxolol on the renal response to postural changes in moderate hypertension.
Madonna O; Labeeuw M; Pozet N; Aissa AH; Zech P
Int J Clin Pharmacol Ther Toxicol; 1988 Mar; 26(3):133-7. PubMed ID: 3410595
[TBL] [Abstract][Full Text] [Related]
16. Effect of lacidipine, a dihydropyridine calcium antagonist on renal function of hypertensive patients with renal insufficiency.
Bailey RR; Shand BI; Smith AH; Robson RA; Lynn KL
Clin Nephrol; 1997 Oct; 48(4):224-9. PubMed ID: 9352156
[TBL] [Abstract][Full Text] [Related]
17. Effect of doxazosin on blood pressure and renal haemodynamics of hypertensive patients with renal failure.
Bailey RR; Nairn PL; Walker RJ
N Z Med J; 1986 Dec; 99(815):942-5. PubMed ID: 2949169
[TBL] [Abstract][Full Text] [Related]
18. Penbutolol in black hypertensive patients.
Venter CP; Joubert PH
S Afr Med J; 1986 Mar; 69(5):286-7. PubMed ID: 3515587
[TBL] [Abstract][Full Text] [Related]
19. [Comparative studies with beta blockers in hypertensive patients in ambulatory care].
Hagel F
Med Welt; 1982 Feb; 33(5):185-7. PubMed ID: 7070274
[No Abstract] [Full Text] [Related]
20. Use of fixed doses of beta blocking drugs in the treatment of hypertension. Randomised study of atenolol and penbutolol.
Lameijer LD; Voermans LA; Houtzagers JJ; Chadha DR
Eur J Clin Pharmacol; 1981; 21(2):93-6. PubMed ID: 7042370
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
